Utilizing Engineered E. Coli as An Asymmetric Biocatalyst towards Pharmaceutical Precursors

Presenters/Authors

Brent D. Feske, Georgia Southern UniversityFollow

Document Type

Presentation

Presentation Date

1-1-2009

Abstract or Description

This presentation was given at SERMACS.

Sponsorship/Conference/Institution

SERMACS

Location

San Juan, Puerto Rico

Recommended Citation

Feske, Brent D.. 2009. "Utilizing Engineered E. Coli as An Asymmetric Biocatalyst towards Pharmaceutical Precursors." Biochemistry, Chemistry, & Physics Faculty & Staff Presentations (1990-2022). Presentation 237.
https://digitalcommons.georgiasouthern.edu/chem-facpres/237